|
OCRL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70007999999999E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.076060E-02 |
| Normal-vs-Stage2 |
4.175700E-02 |
| Normal-vs-Stage3 |
1.615000E-03 |
| Normal-vs-Stage4 |
4.162400E-01 |
| Stage1-vs-Stage2 |
1.271350E-01 |
| Stage1-vs-Stage3 |
1.363880E-02 |
| Stage1-vs-Stage4 |
9.144200E-01 |
| Stage2-vs-Stage3 |
5.456600E-01 |
| Stage2-vs-Stage4 |
3.079400E-01 |
| Stage3-vs-Stage4 |
2.881800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.60990000000116E-05 |
| Normal-vs-AfricanAmerican |
1.298290E-02 |
| Normal-vs-Asian |
3.447600E-02 |
| Caucasian-vs-AfricanAmerican |
7.437800E-01 |
| Caucasian-vs-Asian |
9.558400E-01 |
| AfricanAmerican-vs-Asian |
9.434400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.503500E-03 |
| Normal-vs-Female |
1.05050000032136E-07 |
| Male-vs-Female |
3.88730000000503E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.460200E-03 |
| Normal-vs-Extreme_Weight |
6.005500E-02 |
| Normal-vs-Obese |
5.976000E-04 |
| Normal-vs-Extreme_Obese |
4.947000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.405630E-01 |
| Normal_Weight-vs-Obese |
2.393800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.524000E-01 |
| Extreme_Weight-vs-Obese |
1.744210E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.847600E-01 |
| Obese-vs-Extreme_Obese |
3.095800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.784280E-03 |
| Normal-vs-Age(41-60Yrs) |
4.76790000036864E-07 |
| Normal-vs-Age(61-80Yrs) |
1.699840E-02 |
| Normal-vs-Age(81-100Yrs) |
7.465000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.273900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.311950E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.181710E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.242400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.484200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.934600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.985180E-04 |
| Normal-VS-Type2 PRCC |
1.831820E-02 |
| Normal-VS-KIRP CIMP |
8.817500E-03 |
| Normal-VS-Unclassified PRCC |
3.162800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.765600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.704100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.275200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.835090E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.962790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.083900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.354400E-02 |
| Normal-vs-N1 |
9.643700E-03 |
| Normal-vs-N2 |
5.364300E-02 |
| N0-vs-N1 |
8.291900E-02 |
| N0-vs-N2 |
7.811300E-04 |
| N1-vs-N2 |
1.585830E-01 |
|
|
